Gold Sponsor of Friends for Life Orlando 2021


Friends for Life Orlando 2021 Booth Hours (All Times Eastern US)
In-Person Exhibition Hall Hours
Wednesday, July 7 - 6:00 - 9:00 PM
Thursday, July 8 - 8:00 AM - 4:00 PM
Friday, July 9 - 8:00 AM - 4:00 PM
Virtual Exhibition Hall Hours
Wednesday, July 7 - 6:00 - 7:00 PM
Thursday, July 8 - 5:00 - 6:00 PM
Special Product Showcase
At Tandem Diabetes Care, we understand that kids want a say when it comes to choosing how to manage their diabetes. We’ve made that choice easier for them and their parents by designing a system that helps to keep diabetes under control. The t:slim X2 insulin pump with Control-IQ® technology uses Dexcom G6 Continuous Glucose Monitoring (CGM, sold separately) values to predict glucose levels 30 minutes ahead and adjust insulin dosing, deliver automatic correction boluses when needed, and offers easily personalized Sleep Activity and Exercise Activity settings. So, kids can just be kids.

Virtual Booth Sessions
Great Advice on Disconnecting Your Insulin Pump Infusion Site (And How Easy It Is)

Better Sleep Leads to Better Mornings (Thanks to Your t:slim X2 Insulin Pump)

Kids and parents are loving the t:slim X2 insulin pump with Control-IQ technology

The T1D community sleeps better thanks to the t:slim X2 insulin pump with Control-IQ technology

About Tandem Diabetes Care
At Tandem Diabetes Care, we’re dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience — that includes kids and parents. We know that empowering kids to make smart decisions when it comes to their diabetes management is a conversation for the entire household, which is why we’re thrilled to be returning to CWD.
Learn more about the t:slim X2 insulin pump and Control-IQ technology
How Control-IQ Technology Works on the t:slim X2 Insulin Pump

This video provides a brief overview of how Control-IQ technology works with your t:slim X2 insulin pump to help manage your diabetes on a day-to-day basis by predicting and helping prevent both highs and lows. The video explains how Control-IQ advanced hybrid closed-loop technology is designed to help increase time in range (70-180 mg/dL)* using Dexcom G6 CGM values to predict glucose levels 30 minutes ahead and adjust insulin delivery accordingly; including delivery of automatic correction boluses† as needed.
*As measured by CGM
† If glucose values are predicted to be above 180 mg/dL, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL and delivers 60% of that value. It will do this up to once per hour as needed.
Resources for the t:slim X2 insulin pump and Control-IQ technology
Zoom Backgrounds
For everyone who’s going to do CWD from home, here’s a chance to spruce up your virtual experience.
RESPONSIBLE USE STATEMENT: Control-IQ technology does not prevent all high and low blood glucose events, and is not a substitute for meal boluses and active self-management of your diabetes. Control-IQ technology will not be able to predict sensor glucose values and adjust insulin dosing if your CGM is not working properly or is unable to communicate with your pump. Always pay attention to your symptoms and blood glucose levels and treat accordingly. Please visit tandemdiabetes.com/tslimX2-use for more information.
Important Safety Information:
RX ONLY.
Indications for Use:
t:slim X2 insulin pump
The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in individuals six years of age and greater. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use with NovoLog or Humalog U-100 insulin.
Control-IQ technology
Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater. Control-IQ technology is intended for single patient use. Control-IQ technology is indicated for use with NovoLog or Humalog U-100 insulin.
Contraindications and Warnings:
WARNING: Control-IQ Technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.
Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea.
Users of the t:slim X2 pump and Control-IQ technology must:
- be able and willing to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use;v
- test blood glucose levels as recommended by their healthcare provider;
- demonstrate adequate carb-counting skills;
- maintain sufficient diabetes self-care skills;
- see healthcare provider(s) regularly; and
- have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders.
The t:slim X2 pump, and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.